News Roundup: Routine Pediatric Vaccinations Lag Amid Pandemic, FDA Approves Steroid-Free Antihistamine Allergy Nasal Spray
Here’s a roundup of the latest news coverage from Drug Topics®.
Don’t waste time digging through articles to find the most up-to-date and important news. Drug Topics® has you covered with our weekly news roundup of the latest pharmacy-related news you should know before the weekend begins.
Here’s a roundup of the latest news coverage from Drug Topics®.
Blood-Brain Barrier Crossing Antihypertensives Linked to Less Memory Decline
Blood-brain barrier crossing medicines have shown memory benefits in elderly patients, according to a new analysis.
FDA OKs OTC Use of Steroid-Free Antihistamine Allergy Nasal Spray
The FDA has approved OTC azelastine HCl .15% (Astepro Allergy; Bayer).
Routine Pediatric Vaccinations Continue to Lag Amid COVID-19 Pandemic
There was a marked decline in child and adolescent routine vaccine administration during the COVID-19 pandemic between March and September 2020; these vaccination rates have continued to lag behind.
New Data Show Combination Antibody Treatment Reduces Risk of Death in Hospitalized COVID-19 Patients
The RECOVERY study demonstrated that an antibody combination therapy (REGEN-COV; Regeneron) improved survival in hospitalized patients, a first for COVID-19 antibody treatments.
FDA Approves Oral Blood Thinner For Children
The FDA approved Pradaxa (dabigatran etexilate) to treat venous thromboembolism in children aged 3 months to less than 12 years.
Read more on Contemporary Pediatrics
Half of Latinx, Black Medicare Beneficiaries Choose Medicare Advantage
Fifty-three percent of Latinx and 49% of Black Medicare beneficiaries choose enrollment in Medicare Advantage; seeing average annual savings of $1,113 and $1,270, respectively, compared to Traditional Medicare.
